2026-10-25
Jerash holdings (US) clears the business-activity screen and the figures we can measure look clean, but one or more financial figures are still pending, so the verdict is not final yet.
NAS100 27,087 +1.72%
S&P 7,401 +0.65%
GOLD $4,073 −1.00%
BTC $75,828 −0.15%
VIX 24.55 −12.88%
latest tape · as of 20:03 UTC
The Screen · Consumer Cyclical · Apparel Manufacturing
Jerash holdings (US) Inc
JRSH · NASDAQ · USD · Market cap $78M · 6,000 employees
Jerash Holdings (US), Inc., through its subsidiaries, manufactures and exports customized, ready-made sportswear, and outerwear through knitted fabrics.
Not yet scored5.87 USD
Price as of 5 Nov 2026Daily close, not a live quote
Screened 2026-11-05 · the tape above runs as of 20:03 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
- Price5.87 USD at the 5 Nov 2026 close
- Our value readUndervalued vs our fair value, as of 5 Nov 2026
- Our regime readDistribution, as of 5 Nov 2026
- Ethical screenNot yet scored
- Last reviewed5 Nov 2026 (1 days ago)
- Release timesRelease and earnings times on your chart: Event Guard Mentor
A summary of the dated readings below, not a live quote and not advice.
PRICE · ONE YEAR
Our fair-value range: $7.00 to $11.62, base estimate $7.00 (screen dated 2026-11-05).
- Trend Distribution
- Insiders no filings inside 60 days, left as found
- Positioning no disclosures inside 60 days, left as found
- Options no verdict drawn today, left as found
- Ethical screen not yet scored
Price5.87 USD
Fair value7.00
Ethical score70.0/100
Value readUndervaluedas of 5 Nov 2026
Our investment reviews on this name
2026-09-03Read Markup5.47+7.4% to today ✓Distribution gives way to Markup after a 58% rise in 9 weeks
2026-07-02Read Distribution3.46+69.7% to today First review on file: Distribution
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
The full research record, in depth, below
This name holds its distribution label.
Jerash holdings (US) Inc holds its Distribution at $5.87. Consolidating, no directional conviction, held for 32 days.
| Phase | Distribution · caution |
| Quantitative state | Consolidating, no directional conviction, held for 32 days |
| Price at the screen | $5.87 |
| Valuation | 16.13 trailing · 9.73 forward price to earnings |
| Values screen | Not scored · score 70.0 |
| Beta | 0.97 |
Five Screens, Shown in Full
This security has not been fully scored against the values screen yet.
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 9.55% | Below 33% | Interest-bearing debt is just 9.6% of its assets, well under the one-third ceiling: it does not run on borrowed money. | Pass |
| Interest-bearing cash | 0.00% | Below 33% | Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit. | Pass |
| Receivables | 18.30% | Below 49% | Money owed to the company is 18.3% of assets, under the 49% limit. | Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical ReadThe Read, in Plain English
Jerash holdings (US) clears the business-activity screen and the figures we can measure look clean, but one or more financial figures are still pending, so the verdict is not final yet.
Read as at 2026-11-05. It updates when the underlying figures move, and past reads are kept below.
2026-09-24
Clears
Jerash holdings (US) clears all five screens. Its business is in a permissible area, its interest-bearing debt is about 10%, inside the ~33% line, and almost none of its income is interest, so it passes.
Earlier reads, kept as written. The ethical profile is tracked over time, not overwritten.
What the Numbers Say It Is WorthThe Fair Value Range
Our analysis reads Undervalued vs our fair value, as of 5 Nov 2026: it trades at roughly a 17% discount to our $7.00 fair value, none competitive moat, 26.70% revenue growth.
How a fair value is estimated: discounted cash flow (DCF).
Fair value range in USD, drawn from the 2026-11-05 screen. The gold marker is the market price at the same screen. A 16.1% discount to the base estimate.
Third-party analyst targets. The average target sits +11% from the screen price.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & ProjectionsWhere our models see it going: fair-value estimate $7.00, with a range of $7.00 to $11.62, dated to the 2026-11-05 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsWhy it stands out
A 27%-growth business trading at just 9.7x forward earnings, with a none competitive moat and minimal debt. That is a 17% discount to our $7.00 fair value: the market is pricing it cautiously while the fundamentals argue otherwise.
| Forward P/E | 9.7xcheap for a company growing this fast |
| Trailing P/E | 16.1xreasonably valued |
| EPS, trailing | 0.38 |
| EPS, forward | 0.63 |
| Revenue growth | +26.7%strong top-line growth |
| Profit margin | 2.8%barely profitable |
| Return on equity | 7.7%a modest return on shareholder capital |
| FCF yield | 7.84% |
| Dividend yield | 576.00% |
| Debt to equity | 0.14minimal debt: a conservative balance sheet |
| Current ratio | 3.11comfortably covers its short-term bills |
| Beta | 0.97steadier than the market |
| Short interest, float | 0.00% |
| 52-week range | 2.85 - 6.67 |
| Moat | NONE |
| Market cap | $78M |
| Employees | 6,000 |
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The things to watch: it's a small-cap, so the share price can swing harder than the market.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeJRSH trades on NASDAQ. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
2026-11-01
Markup $5.93
-3.7% Entry 8
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 3.7% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 49% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 22%. Our forward projection puts the odds of a 10% gain over the next month near 18%. The street (2 analysts) rates it strong buy, with a mean price target of $6.
2026-10-19
Markup $6.16
+7.3% Entry 7
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 7.3% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 53% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 22%. Our forward projection puts the odds of a 10% gain over the next month near 18%. The street (2 analysts) rates it strong buy, with a mean price target of $6.
2026-10-02
Markup $5.74
+5.0% Entry 6
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 5.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading bullish. Over the past year the shares are up 22%. Our forward projection puts the odds of a 10% gain over the next month near 18%. The street (2 analysts) rates it strong buy, with a mean price target of $6.
2026-09-03
Markup · changed $5.47
+21.2% Entry 5
The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 21.2% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading bullish. Over the past year the shares are up 22%. Our forward projection puts the odds of a 10% gain over the next month near 18%. The street (2 analysts) rates it strong buy, with a mean price target of $6.
2026-08-03
Distribution $4.51
+30.3% Entry 4
Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved up 30.3% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading bullish. Over the past year the shares are up 22%. Our forward projection puts the odds of a 10% gain over the next month near 18%. The street (2 analysts) rates it strong buy, with a mean price target of $6.
2026-07-18
Distribution $3.46
+0.0% Entry 3
Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading bullish. Over the past year the shares are up 22%. Our forward projection puts the odds of a 10% gain over the next month near 18%. The street (2 analysts) rates it strong buy, with a mean price target of $6.
2026-07-03
Distribution $3.46
+0.0% Entry 2
Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows good risk-adjusted returns.
2026-07-02
Distribution $3.46
Entry 1
Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows good risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- Jerash Holdings Announces Results of 2026 Annual Meeting of Stockholders Yahoo Finance · 11 Sep 2026
- Jerash Holdings to Present at Lake Street's 10th Annual Best Ideas Growth Conference, September 10 Yahoo Finance · 20 Aug 2026
- Jerash Holdings (US) Inc (JRSH) (Q1 2027) Earnings Call Highlights: Record Revenue and Fivefold ... GuruFocus.com · 10 Aug 2026
- Jerash Holdings (US) Inc (JRSH) (Q1 2027) Earnings Call Highlights: Record Revenue and Fivefold ... Yahoo Finance · 10 Aug 2026
- Jerash Holdings (US) Q1 Earnings Call Highlights MarketBeat · 10 Aug 2026
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
VNCEVince Holding Corp
JXGJX Luxventure Group Inc
PLCEChildrens Place Inc
LAKELakeland Industries Inc
NCINeo Concept International Group Holdings Ltd
SGCSuperiorGroup of Companies Inc
Screened names in the same industry · explore each on its own page.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $3.30 | +9.6% | $0.05 | $1,111 | +11.1% |
| 2 months | $3.05 | +18.4% | $0.05 | $1,200 | +20.0% |
| 3 months | $3.00 | +20.4% | $0.05 | $1,220 | +22.0% |
| 6 months | $3.00 | +20.7% | $0.10 | $1,240 | +24.0% |
| 1 year | $2.96 | +22.1% | $0.20 | $1,288 | +28.8% |
| 2 years | $2.68 | +34.9% | $0.40 | $1,498 | +49.8% |
| 3 years | $3.47 | +4.2% | $0.60 | $1,215 | +21.5% |
| 5 years | $4.90 | -26.2% | $1.00 | $942 | -5.8% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever JRSH does next, these words stay.
Membership
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.